Answers are grounded in this paper and cite their sources.
ZMYND8, a chromatin reader with dual histone and methylation recognition capacity, has been implicated in various cellular processes, yet the upstream regulatory mechanisms controlling ZMYND8 expression in breast cancer (BC) remain incompletely understood. Here, we demonstrate that ZMYND8 is markedly upregulated in BC tissues and selected cell lines. Functionally, genetic silencing of ZMYND8 inhibits cell proliferation, suppresses clonogenicity, induces apoptosis, and impairs migratory and invasive capabilities in BC cells. Mechanistically, we identify ZMYND8 mRNA as an m⁶A-modified transcript. Integrated analysis of TCGA-BRCA and experimental validation reveal that METTL14, an m⁶A methyltransferase, enhances ZMYND8 expression by promoting m⁶A modification and stabilizing its mRNA transcript. Moreover, the m⁶A reader YTHDF1 binds to methylated ZMYND8 mRNA in a METTL14-dependent manner and safeguards its stability. Collectively, our findings uncover a METTL14–YTHDF1–ZMYND8 regulatory axis that facilitates BC progression and highlight ZMYND8 as a potential epitranscriptomic effector in BC.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: